Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

HTT decreases the amount of ATXN3. 3 / 3

| 3

➶

reach

"Similarly, Htt 100Q -N90 could also reduce the total Atx3 level."

33837238

➶

reach

"The results showed that, NLS-Atx7 93Q -N172 and Htt 100Q -N90 both caused reduction of the soluble Atx3 level, while MG132 treatment, to some extent, could reverse the decrease of Atx3 in the supernatant fraction."

33837238

➶

reach

"PQE Atx7 and Htt reduce the overall level of intracellular Atx3."

33837238

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

HTT decreases the amount of ATXN3. 3 / 3

Our Sources:

Databases

Reading